OCULAR THERAPEUTIX, INC Cash And Cash Equivalents At Carrying Value

Quick Answer

OCULAR THERAPEUTIX, INC reported Cash And Cash Equivalents At Carrying Value of $737.06 million for the year ending 2025.

  • OCULAR THERAPEUTIX, INC showed an increase of +88.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from OCULAR THERAPEUTIX, INC's annual report (Form 10-K), filed with the SEC on February 5, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), OCULAR THERAPEUTIX, INC's Cash And Cash Equivalents At Carrying Value has grown by 13,728.5%.
  • Historical annual values: Fiscal year 2025: $737.06 million | Fiscal year 2024: $392.10 million | Fiscal year 2023: $195.81 million | Fiscal year 2022: $102.30 million | Fiscal year 2021: $164.16 million | Fiscal year 2020: $228.06 million | Fiscal year 2019: $54.44 million | Fiscal year 2018: $54.06 million | Fiscal year 2017: $41.54 million | Fiscal year 2016: $32.94 million | Fiscal year 2015: $30.78 million | Fiscal year 2014: $37.39 million | Fiscal year 2013: $17.51 million | Fiscal year 2012: $23.85 million | Fiscal year 2011: $5.33 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: